Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2021; 31(02): 383-390
DOI: 10.1055/s-0041-1734366
Case Series

Loes Score: Clinical and Radiological Profile of 22 Patients of X-Linked Adrenoleukodystrophy: Case Series from a Single Center

Somesh Kumar 
1   Division of Genetics and Metabolism, Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
,
Haseena Sait
1   Division of Genetics and Metabolism, Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
,
Sunil K. Polipalli
1   Division of Genetics and Metabolism, Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
,
Gaurav S. Pradhan
2   Department of Radiodiagnosis, Maulana Azad Medical College, New Delhi, India
,
Sumit Pruthi
3   Vanderbilt University Medical Centre, Nashville, Tennessee, United States
,
Seema Kapoor
1   Division of Genetics and Metabolism, Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction X-linked adrenoleukodystrophy (X-ALD) is a devastating disease with a wide spectrum of presentation ranging from asymptomatic to a rapidly progressive childhood cerebral form. The gene responsible for adrenoleukodystrophy is ABCD1 gene, required for β oxidation of fatty acids in various tissues. While biochemical and molecular techniques are available to confirm the diagnosis, brain magnetic resonance imaging (MRI) utilizing Loes score has been used for both prognosis and timely direction of hematopoietic stem cell therapy.

Materials and Methods During the study period of 2016 to 2020, 22 individuals including 19 individuals with features suggestive of X-ALD and 3 asymptomatic siblings were evaluated from a single center in North India. After biochemical and molecular confirmation of the disease, detailed clinical and radiological findings using MRI brain were documented. A radiological scoring pattern proposed by Loes was employed to identify the severity of the disorder.

Results The most common clinical presentations were visual difficulty and muscular weakness (58%). All symptomatic individuals had classic neuroimaging findings in the form of hyperintensities involving the parieto-occipital area and splenium of corpus callosum. Severe involvement in the form of global atrophy was observed in 52.6% of individuals. Asymptomatic siblings also showed neurological involvement based on MRI with highest Loes score of 9 in one individual.

Conclusion This case series describes the clinical and radiological profile and employment of Loes score in individuals with X-ALD. Early identification of asymptomatic individuals by neuroimaging and use of Loes severity score for monitoring and disease progression will help in making therapeutic decisions in a timely manner.

Keywords

adrenoleukodystrophy - Loes score - magnetic resonance imaging - very long chain fatty acids


Publication History

Article published online:
28 July 2021

© 2021. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 2005; 294 (24) 3131-3134
    CrossrefPubMedGoogle Scholar
  • 2 Wiesinger C, Eichler FS, Berger J. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 2015; 8: 109-121
    PubMedGoogle Scholar
  • 3 Eichler F, Duncan C, Musolino PL. et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 2017; 377 (17) 1630-1638
    CrossrefPubMedGoogle Scholar
  • 4 Kemper AR, Brosco J, Comeau AM. et al. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med 2017; 19 (01) 121-126
    CrossrefPubMedGoogle Scholar
  • 5 Loes DJ, Hite S, Moser H. et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994; 15 (09) 1761-1766
    PubMedGoogle Scholar
  • 6 Peters C, Charnas LR, Tan Y. et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004; 104 (03) 881-888
    CrossrefPubMedGoogle Scholar
  • 7 Suzuki Y, Isogai K, Teramoto T. et al. Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis 2000; 23 (05) 453-458
    CrossrefPubMedGoogle Scholar
  • 8 Musolino PL, Gong Y, Snyder JM. et al. Brain endothelial dysfunction in cerebral adrenoleukodystrophy. Brain 2015; 138 (11) 3206-3220
    CrossrefPubMedGoogle Scholar
  • 9 Kim JH, Kim HJ. Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics 2005; 25 (03) 619-631
    CrossrefPubMedGoogle Scholar
  • 10 Liberato AP, Mallack EJ, Aziz-Bose R. et al. MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy. Neurology 2019; 92 (15) e1698-e1708
    CrossrefPubMedGoogle Scholar
  • 11 Loes DJ, Fatemi A, Melhem ER. et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003; 61 (03) 369-374
    CrossrefPubMedGoogle Scholar
  • 12 Patay Z. Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 2005; 15 (11) 2284-2303
    CrossrefPubMedGoogle Scholar
  • 13 Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001; 56 (03) 304-311
    CrossrefPubMedGoogle Scholar
  • 14 Ono SE, de Carvalho Neto A, Gasparetto EL. et al. X-linked adrenoleukodystrophy: correlation between Loes score and diffusion tensor imaging parameters. Radiol Bras 2014; 47 (06) 342-349
    CrossrefPubMedGoogle Scholar
  • 15 Warren DJ, Connolly DJA, Wilkinson ID, Sharrard MJ, Griffiths PD. Magnetic resonance spectroscopy changes following haemopoietic stem cell transplantation in children with cerebral adrenoleukodystrophy. Dev Med Child Neurol 2007; 49 (02) 135-139
    CrossrefPubMedGoogle Scholar
  • 16 Bladowska J, Kulej D, Biel A. et al. The role of MR imaging in the assessment of clinical outcomes in children with X-linked adrenoleukodystrophy after allogeneic haematopoietic stem cell transplantation. Pol J Radiol 2015; 80: 181-190
    CrossrefPubMedGoogle Scholar
  • 17 Main.mohfw.gov.in. 2020 [cited 29 November 2020]. Available from: https://main.mohfw.gov.in/sites/default/files/RAN_Guideline_2019.pdf. Accessed July 21, 2020